Next-Generation Weight Loss Technology
FDA-approved November 2023. Not in Nigeria yet.
The biotech revolution is coming.
Zepbound represents the next evolution in weight loss pharmacology. Approved by the FDA in November 2023, it contains tirzepatide - the same groundbreaking molecule found in Mounjaro.
What makes it revolutionary? Tirzepatide is a dual-agonist - it simultaneously activates both GLP-1 and GIP receptors in your body, creating a synergistic effect that single-target medications cannot match.
WEIGHT_REDUCTION
Published clinical research (72 weeks)
WEEKS_DURATION
PARTICIPANTS
1 in 3 participants lost 25%+ of their body weight - unprecedented in pharmacological weight management.
Zepbound has not been registered with Nigeria's National Agency for Food and Drug Administration and Control. Without this registration, legal distribution is impossible.
Eli Lilly has not established distribution channels anywhere in Africa. Focus remains on US and European markets where shortages persist.
Only FDA-approved in November 2023. Even in the US, stable supply took months. African markets are realistically years away from official access.
Global demand far exceeds current manufacturing capacity. Priority markets receive allocation first.
While Zepbound isn't available, compounded tirzepatide is. Identical active ingredient - without Eli Lilly's branding and pricing.
No. Zepbound is not available in Nigeria or anywhere in Africa. It was approved by the FDA in November 2023 for the United States market only. Eli Lilly has not registered Zepbound with NAFDAC or established distribution in Nigeria. Anyone claiming to sell "authentic Zepbound" in Nigeria is likely selling counterfeit products.
They contain the exact same active ingredient - tirzepatide - made by the same company (Eli Lilly). The only difference is their FDA-approved use: Mounjaro is approved for Type 2 diabetes, while Zepbound is specifically approved for weight management. Same medication, different packaging and indications.
While branded Zepbound or Mounjaro are not available, compounded tirzepatide with the same active ingredient can be obtained through licensed healthcare providers. Contact a licensed compounding pharmacy for information about legitimate options with proper medical consultation and cold-chain delivery.
Compounded tirzepatide contains the same active molecule as Zepbound. When obtained from a legitimate compounding pharmacy and used under medical supervision, it should provide equivalent results. Published clinical research on the tirzepatide molecule has shown clinically significant weight loss results.
Unknown. There is no announced timeline for Zepbound availability in Nigeria. Eli Lilly is currently struggling to meet demand in the United States and has not indicated plans for African distribution. Realistically, official availability in Nigeria could be several years away, if it happens at all. In the meantime, compounded tirzepatide remains the accessible option.
Initialize your transformation sequence today with the same powerful tirzepatide molecule. Licensed providers. Verified cold-chain. Real results.